CSIMarket
 


Dariohealth Corp   (DRIO)
Other Ticker:  
 
 

DRIO's Capital Expenditures Growth by Quarter and Year

Dariohealth 's Capital Expenditures results by quarter and year




DRIO Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.00 0.07 0.05
III Quarter September 0.28 0.00 0.10 0.03
II Quarter June 0.15 0.16 0.03 0.01
I Quarter March 0.07 0.18 0.07 0.03
FY   0.50 0.34 0.27 0.12



DRIO Capital Expenditures third quarter 2023 Y/Y Growth Comment
Dariohealth Corp in the third quarter 2023 achieved Capital Expenditures of $ 0.28 millions compare to Capital Expenditures recorded in same quarter a year ago.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 24 other companies have achieved higher Capital Expenditures growth. While Dariohealth Corp ' s Capital Expenditures no change of % ranks overall at the positon no. 445 in the third quarter 2023.




DRIO Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - 40 % 150 %
III Quarter September - - 233.33 % 200 %
II Quarter June -6.25 % 433.33 % 200 % -66.67 %
I Quarter March -61.11 % 157.14 % 133.33 % -40 %
FY   - 25.93 % 125 % 9.09 %

Financial Statements
Dariohealth 's third quarter 2023 Capital Expenditures $ 0.28 millions DRIO's Income Statement
Dariohealth 's third quarter 2022 Capital Expenditures $ 0.00 millions Quarterly DRIO's Income Statement
New: More DRIO's historic Capital Expenditures Growth >>


DRIO Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - -30 % 66.67 %
III Quarter September 87.33 % - 233.33 % 200 %
II Quarter June 114.29 % -11.11 % -57.14 % -66.67 %
I Quarter March - 157.14 % 40 % 50 %
FY (Year on Year)   - 25.93 % 125 % 9.09 %




Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #103
Overall #445

Capital Expenditures Y/Y Growth Statistics
High Average Low
502.86 % 60.41 % -100 %
(Jun 30 2016)   (Sep 30 2022)
Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #103
Overall #445
Capital Expenditures Y/Y Growth Statistics
High Average Low
502.86 % 60.41 % -100 %
(Jun 30 2016)   (Sep 30 2022)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Dariohealth 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
502.86 % 60.41 % -100 %
(Jun 30 2016)  


DRIO's III. Quarter Q/Q Capital Expenditures Comment
Dariohealth Corp achieved in the III. Quarter 2023 above company average sequential Capital Expenditures jump of 87.33%, to $ 0.28 millions, from $0.15 millions in the second quarter.

Within Medical Equipment & Supplies industry 24 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Dariohealth 's Capital Expenditures growth quarter on quarter, overall rank is 445.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #103
Overall #445
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #25
Healthcare Sector #103
Overall #445
Capital Expenditures Q/Q Growth Statistics
High Average Low
502.86 % 60.41 % -100 %
(Jun 30 2016)  


DRIO's III. Quarter Q/Q Capital Expenditures Comment
Dariohealth Corp achieved in the III. Quarter 2023 above company average sequential Capital Expenditures jump of 87.33%, to $ 0.28 millions, from $0.15 millions in the second quarter.

Within Medical Equipment & Supplies industry 24 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Dariohealth 's Capital Expenditures growth quarter on quarter, overall rank is 445.


Dariohealth 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.07
Y / Y Capital Expenditures Growth (TTM) - - - - -71.9 %
Year on Year Capital Expenditures Growth Overall Ranking # 1039 # 91 # 139 # 140 # 2390
Seqeuential Capital Expenditures Change (TTM) - - - - -86.51 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1066 # 761 # 519 # 641 # 2921




Cumulative Capital Expenditures growth Comment
In the Sep 30 2023 period, Dariohealth 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

In the Healthcare sector 124 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 91 to 1039.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
634.55 %
45.3 %
-158.71 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 40
Healthcare Sector # 125
Overall # 1039

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
634.55 %
45.3 %
-158.71 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 136
S&P 500 # 1066
Cumulative Capital Expenditures growth Comment
In the Sep 30 2023 period, Dariohealth 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

In the Healthcare sector 124 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 91 to 1039.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
634.55 %
45.3 %
-158.71 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 40
Healthcare Sector # 125
Overall # 1039

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
634.55 %
45.3 %
-158.71 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 136
S&P 500 # 1066




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
DRIO's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for DRIO's Competitors
Capital Expenditures Growth for Dariohealth 's Suppliers
Capital Expenditures Growth for DRIO's Customers

You may also want to know
DRIO's Annual Growth Rates DRIO's Profitability Ratios DRIO's Asset Turnover Ratio DRIO's Dividend Growth
DRIO's Roe DRIO's Valuation Ratios DRIO's Financial Strength Ratios DRIO's Dividend Payout Ratio
DRIO's Roa DRIO's Inventory Turnover Ratio DRIO's Growth Rates DRIO's Dividend Comparisons



Companies with similar Capital Expenditures jump for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Encompass Health Corporation-0.54%$ -0.542 millions
Myriad Genetics Inc -1.13%$ -1.130 millions
Opgen inc -1.22%$ -1.220 millions
Avantor Inc -3.33%$ -3.333 millions
United Therapeutics Corporation-4.51%$ -4.506 millions
Enanta Pharmaceuticals Inc-4.80%$ -4.802 millions
Davita Inc -5.46%$ -5.463 millions
Science 37 Holdings Inc -5.63%$ -5.630 millions
Cutera Inc -5.71%$ -5.708 millions
Zoetis Inc -5.84%$ -5.844 millions
U S Physical Therapy Inc-6.25%$ -6.248 millions
Generation Bio Co -6.30%$ -6.298 millions
Ngm Biopharmaceuticals Inc -6.45%$ -6.452 millions
Becton Dickinson And Company-6.67%$ -6.667 millions
3m Company-6.90%$ -6.897 millions
Apyx Medical Corporation-7.45%$ -7.447 millions
Edwards Lifesciences Corporation-7.68%$ -7.679 millions
Viatris Inc -7.70%$ -7.700 millions
Luna Innovations Inc-8.23%$ -8.232 millions
Nevro Corp -8.38%$ -8.377 millions
Shockwave Medical Inc -8.65%$ -8.649 millions
Sonendo Inc -8.86%$ -8.861 millions
Charles River Laboratories International inc -8.90%$ -8.904 millions
Nautilus Biotechnology Inc -9.24%$ -9.242 millions
Harvard Bioscience Inc-9.28%$ -9.276 millions
Fulgent Genetics Inc -9.42%$ -9.420 millions
Idexx Laboratories Inc-9.53%$ -9.529 millions
Sage Therapeutics Inc -9.89%$ -9.890 millions
Caredx Inc -10.40%$ -10.400 millions
Quest Diagnostics Inc-11.02%$ -11.017 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com